Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 18058233)

1.

Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase.

Maines LW, Fitzpatrick LR, French KJ, Zhuang Y, Xia Z, Keller SN, Upson JJ, Smith CD.

Dig Dis Sci. 2008 Apr;53(4):997-1012. Epub 2007 Dec 4.

2.

Extraintestinal Helminth Infection Limits Pathology and Proinflammatory Cytokine Expression during DSS-Induced Ulcerative Colitis: A Role for Alternatively Activated Macrophages and Prostaglandins.

Ledesma-Soto Y, Callejas BE, Terrazas CA, Reyes JL, Espinoza-Jiménez A, González MI, León-Cabrera S, Morales R, Olguín JE, Saavedra R, Oghumu S, Satoskar AR, Terrazas LI.

Biomed Res Int. 2015;2015:563425. doi: 10.1155/2015/563425. Epub 2015 May 18.

3.

Allicin Alleviates Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in BALB/c Mice.

Pandurangan AK, Ismail S, Saadatdoust Z, Esa NM.

Oxid Med Cell Longev. 2015;2015:605208. doi: 10.1155/2015/605208. Epub 2015 May 5.

4.

Voluntary exercise protects against ulcerative colitis by up-regulating glucocorticoid-mediated PPAR-γ activity in the colon in mice.

Liu WX, Zhou F, Wang Y, Wang T, Xing JW, Zhang S, Sang LX, Gu SZ, Wang HL.

Acta Physiol (Oxf). 2015 May 30. doi: 10.1111/apha.12534. [Epub ahead of print]

PMID:
26031185
5.

Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy.

Vong LB, Mo J, Abrahamsson B, Nagasaki Y.

J Control Release. 2015 Jul 28;210:19-25. doi: 10.1016/j.jconrel.2015.05.275. Epub 2015 May 19.

PMID:
25998050
6.

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.

Marshall DC, Lyman SK, McCauley S, Kovalenko M, Spangler R, Liu C, Lee M, O'Sullivan C, Barry-Hamilton V, Ghermazien H, Mikels-Vigdal A, Garcia CA, Jorgensen B, Velayo AC, Wang R, Adamkewicz JI, Smith V.

PLoS One. 2015 May 11;10(5):e0127063. doi: 10.1371/journal.pone.0127063. eCollection 2015.

7.

Involvement of stimulation of α7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice.

Tasaka Y, Yasunaga D, Kiyoi T, Tanaka M, Tanaka A, Suemaru K, Araki H.

J Pharmacol Sci. 2015 Mar;127(3):275-83. doi: 10.1016/j.jphs.2014.12.016. Epub 2015 Feb 17.

8.

Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.

Chen G, Yang Y, Liu M, Teng Z, Ye J, Xu Y, Cai X, Cheng X, Yang J, Hu C, Wang M, Cao P.

J Ethnopharmacol. 2015 May 26;166:149-56. doi: 10.1016/j.jep.2015.03.027. Epub 2015 Mar 17.

PMID:
25794808
9.

Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3.

Talero E, Bolivar S, Ávila-Román J, Alcaide A, Fiorucci S, Motilva V.

Inflamm Bowel Dis. 2015 May;21(5):1027-37. doi: 10.1097/MIB.0000000000000346.

PMID:
25793324
10.

KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration.

Watanabe Y, Murata T, Amakawa M, Miyake Y, Handa T, Konishi K, Matsumura Y, Tanaka T, Takeuchi K.

Eur J Pharmacol. 2015 May 5;754:179-89. doi: 10.1016/j.ejphar.2015.02.021. Epub 2015 Feb 19.

11.

[Apocynin relieves inflammation in dextran sulfate sodium-induced ulcerative colitis mice: the role of NOXs-ROS-p38MAPK pathway].

Wei DD, Lin XH, Wang HC, Wang B, Bai CY, Wang YQ, Li GE, Ren XQ.

Sheng Li Xue Bao. 2015 Feb 25;67(1):74-82. Chinese.

12.

Pharmacological activity of 6-gingerol in dextran sulphate sodium-induced ulcerative colitis in BALB/c mice.

Ajayi BO, Adedara IA, Farombi EO.

Phytother Res. 2015 Apr;29(4):566-72. doi: 10.1002/ptr.5286. Epub 2015 Jan 29.

PMID:
25631463
13.

A Chinese medicinal formulation ameliorates dextran sulfate sodium-induced experimental colitis by suppressing the activity of nuclear factor-kappaB signaling.

Tsang SW, Ip SP, Wu JC, Ng SC, Yung KK, Bian ZX.

J Ethnopharmacol. 2015 Mar 13;162:20-30. doi: 10.1016/j.jep.2014.12.035. Epub 2014 Dec 29.

PMID:
25554639
14.

Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease.

Snider AJ, Ali WH, Sticca JA, Coant N, Ghaleb AM, Kawamori T, Yang VW, Hannun YA, Obeid LM.

PLoS One. 2014 Dec 2;9(12):e113998. doi: 10.1371/journal.pone.0113998. eCollection 2014.

15.

Anti-inflammatory effects of orally administered glucosamine oligomer in an experimental model of inflammatory bowel disease.

Azuma K, Osaki T, Kurozumi S, Kiyose M, Tsuka T, Murahata Y, Imagawa T, Itoh N, Minami S, Sato K, Okamoto Y.

Carbohydr Polym. 2015 Jan 22;115:448-56. doi: 10.1016/j.carbpol.2014.09.012. Epub 2014 Sep 21.

PMID:
25439918
16.

[Study on effect of total flavonoids of Oldenlendia difflusa on ulcerative colitis and its immunological mechanism].

Luo SY, Le Z, Lv XH, Zhong ZG.

Zhongguo Zhong Yao Za Zhi. 2014 Mar;39(5):896-900. Chinese.

PMID:
25204186
17.

Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases.

Sobczak M, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Chen C, Sałaga M, Małecka-Panas E, Kordek R, Krajewska WM, Fichna J.

Pharmacol Rep. 2014 Oct;66(5):741-50. doi: 10.1016/j.pharep.2014.03.007. Epub 2014 Apr 4.

PMID:
25149976
18.

Effect of secondary lymphoid tissue chemokine suppression on experimental ulcerative colitis in mice.

Zhang H, Zhang X, Ding X, Cao W, Qu L, Zhou G.

Genet Mol Res. 2014 Apr 29;13(2):3337-45. doi: 10.4238/2014.April.29.12.

19.

Therapeutic activity of an interleukin-4/interleukin-13 dual antagonist on oxazolone-induced colitis in mice.

Kasaian MT, Page KM, Fish S, Brennan A, Cook TA, Moreira K, Zhang M, Jesson M, Marquette K, Agostinelli R, Lee J, Williams CM, Tchistiakova L, Thakker P.

Immunology. 2014 Nov;143(3):416-27. doi: 10.1111/imm.12319.

PMID:
24831554
20.

ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition.

Lin X, Yi Z, Diao J, Shao M, Zhao L, Cai H, Fan Q, Yao X, Sun X.

J Transl Med. 2014 Apr 26;12:105. doi: 10.1186/1479-5876-12-105.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk